Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Should We Collect a Biopsy From This Submucosal Lesion in the Cecum?

Co PV, Benya R, Venu M.

Gastroenterology. 2019 Jan;156(1):34-35. doi: 10.1053/j.gastro.2018.04.041. Epub 2018 Sep 18. No abstract available.

PMID:
30240670
2.

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM.

Cancer Prev Res (Phila). 2015 Mar;8(3):222-30. doi: 10.1158/1940-6207.CAPR-14-0148. Epub 2015 Jan 20.

3.

DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Roy N, Bommi PV, Bhat UG, Bhattacharjee S, Elangovan I, Li J, Patra KC, Kopanja D, Blunier A, Benya R, Bagchi S, Raychaudhuri P.

Cancer Res. 2013 Jun 15;73(12):3771-82. doi: 10.1158/0008-5472.CAN-12-4069. Epub 2013 Apr 22.

4.

Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation.

Tell R, Wang QT, Blunier A, Benya RV.

Clin Epigenetics. 2011 Aug;2(2):331-8. doi: 10.1007/s13148-011-0027-5. Epub 2011 Mar 29.

5.

Estrogen receptor-β protects against colitis-associated neoplasia in mice.

Saleiro D, Murillo G, Benya RV, Bissonnette M, Hart J, Mehta RG.

Int J Cancer. 2012 Dec 1;131(11):2553-61. doi: 10.1002/ijc.27578. Epub 2012 Apr 27.

6.

Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.

Peng X, Tiwari N, Roy S, Yuan L, Murillo G, Mehta RR, Benya RV, Mehta RG.

J Endocrinol. 2012 Feb;212(2):207-15. doi: 10.1530/JOE-11-0305. Epub 2011 Nov 8.

PMID:
22068926
7.

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE.

Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Erratum in: Cancer Prev Res (Phila). 2012 Dec;5(12):1407. Dosage error in article text.

8.

Gastrin-releasing peptide signaling alters colon cancer invasiveness via heterochromatin protein 1Hsβ.

Tell R, Rivera CA, Eskra J, Taglia LN, Blunier A, Wang QT, Benya RV.

Am J Pathol. 2011 Feb;178(2):672-8. doi: 10.1016/j.ajpath.2010.10.017.

9.

Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.

Limburg PJ, Mahoney MR, Ziegler KL, Sontag SJ, Schoen RE, Benya R, Lawson MJ, Weinberg DS, Stoffel E, Chiorean M, Heigh R, Levine J, Della'Zanna G, Rodriguez L, Richmond E, Gostout C, Mandrekar SJ, Smyrk TC; Cancer Prevention Network.

Cancer Prev Res (Phila). 2011 Feb;4(2):259-69. doi: 10.1158/1940-6207.CAPR-10-0215. Epub 2011 Jan 5.

10.

Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.

Ao M, Venkatasubramanian J, Boonkaewwan C, Ganesan N, Syed A, Benya RV, Rao MC.

Dig Dis Sci. 2011 Feb;56(2):339-51. doi: 10.1007/s10620-010-1495-8. Epub 2010 Dec 8.

PMID:
21140215
11.

Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer.

Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):403-7. doi: 10.1016/j.jsbmb.2010.03.009. Epub 2010 Mar 7.

12.

Rotavirus infection of murine small intestine causes colonic secretion via age restricted galanin-1 receptor expression.

Hempson SJ, Matkowskyj K, Bansal A, Tsao E, Habib I, Benya R, Mackow ER, Shaw RD.

Gastroenterology. 2010 Jun;138(7):2410-7. doi: 10.1053/j.gastro.2010.02.050. Epub 2010 Mar 1.

PMID:
20197068
13.

Age-dependent differences in galanin-dependent colonic fluid secretion after infection with Salmonella typhimurium.

Matkowskyj K, Royan SV, Blunier A, Hecht G, Rao M, Benya RV.

Gut. 2009 Sep;58(9):1201-6. doi: 10.1136/gut.2008.163832.

PMID:
19671554
14.

Expression of GRP and its receptor is associated with improved survival in patients with colon cancer.

Rivera CA, Ahlberg NC, Taglia L, Kumar M, Blunier A, Benya RV.

Clin Exp Metastasis. 2009;26(7):663-71. doi: 10.1007/s10585-009-9265-8. Epub 2009 May 10.

PMID:
19430935
15.

Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening.

Kim J, Rami P, O'Toole J, Llor X, Carroll RE, Benya RV.

Colorectal Dis. 2010 May;12(5):471-6. doi: 10.1111/j.1463-1318.2009.01822.x. Epub 2009 Feb 27.

PMID:
19298579
16.

Aberrant crypt focus size predicts distal polyp histopathology.

Kim J, Ng J, Arozulllah A, Ewing R, Llor X, Carroll RE, Benya RV.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1155-62. doi: 10.1158/1055-9965.EPI-07-2731.

17.

GRP-induced up-regulation of Hsp72 promotes CD16+/94+ natural killer cell binding to colon cancer cells causing tumor cell cytolysis.

Taglia L, Matusiak D, Benya RV.

Clin Exp Metastasis. 2008;25(4):451-63. doi: 10.1007/s10585-008-9151-9. Epub 2008 Mar 19.

PMID:
18350254
18.
19.

CYP27A1 and CYP24 expression as a function of malignant transformation in the colon.

Matusiak D, Benya RV.

J Histochem Cytochem. 2007 Dec;55(12):1257-64. Epub 2007 Sep 17.

PMID:
17875655
20.

Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer.

Murillo G, Matusiak D, Benya RV, Mehta RG.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):763-7. Epub 2007 Jan 24.

21.

Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.

Taglia L, Matusiak D, Matkowskyj KA, Benya RV.

Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G182-90. Epub 2006 Aug 17.

22.

Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach.

Ruginis T, Taglia L, Matusiak D, Lee BS, Benya RV.

J Proteome Res. 2006 Jun;5(6):1460-8.

PMID:
16739997
23.

Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer.

Hu Y, Benya RV, Carroll RE, Diamond AM.

J Nutr. 2005 Dec;135(12 Suppl):3021S-3024S. doi: 10.1093/jn/135.12.3021S. Review.

PMID:
16317164
24.

Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon.

Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2370-6.

25.

Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling.

Glover S, Nathaniel R, Shakir L, Perrault C, Anderson RK, Tran-Son-Tay R, Benya RV.

Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1274-82.

26.

Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.

Matusiak D, Glover S, Nathaniel R, Matkowskyj K, Yang J, Benya RV.

Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G718-28. Epub 2004 Nov 4.

27.

Galanin contributes to the excess colonic fluid secretion observed in dextran sulfate sodium murine colitis.

Matkowskyj KA, Nathaniel R, Prasad R, Weihrauch D, Rao M, Benya RV.

Inflamm Bowel Dis. 2004 Jul;10(4):408-16.

PMID:
15475749
28.

Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties.

Glover S, Delaney M, Dematte C, Kornberg L, Frasco M, Tran-Son-Tay R, Benya RV.

J Cell Physiol. 2004 Apr;199(1):77-88.

PMID:
14978737
29.

Importance of amino acids of the central portion of the second intracellular loop of the gastrin-releasing Peptide receptor for phospholipase C activation, internalization, and chronic down-regulation.

Schumann M, Nakagawa T, Mantey SA, Tokita K, Venzon DJ, Hocart SJ, Benya RV, Jensen RT.

J Pharmacol Exp Ther. 2003 Nov;307(2):597-607. Epub 2003 Sep 11.

PMID:
12970386
30.

Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407.

Matkowskyj KA, Keller K, Glover S, Kornberg L, Tran-Son-Tay R, Benya RV.

J Histochem Cytochem. 2003 Aug;51(8):1041-8.

PMID:
12871985
31.

Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.

Glover SC, Tretiakova MS, Carroll RE, Benya RV.

Mol Carcinog. 2003 May;37(1):5-15.

PMID:
12720295
32.

Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number.

Matkowskyj KA, Cox R, Jensen RT, Benya RV.

J Histochem Cytochem. 2003 Feb;51(2):205-14.

PMID:
12533529
33.

Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract.

Carroll RE, Matkowskyj K, Saunthararajah Y, Sekosan M, Battey JF, Benya RV.

Mech Dev. 2002 May;113(2):121-30.

34.
35.

Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes.

Benya RV, Kusui T, Katsuno T, Tsuda T, Mantey SA, Battey JF, Jensen RT.

Mol Pharmacol. 2000 Dec;58(6):1490-501.

PMID:
11093789
36.

Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens.

Matkowskyj KA, Danilkovich A, Marrero J, Savkovic SD, Hecht G, Benya RV.

Nat Med. 2000 Sep;6(9):1048-51.

PMID:
10973327
37.

Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines.

Carroll RE, Ostrovskiy D, Lee S, Danilkovich A, Benya RV.

Mol Pharmacol. 2000 Sep;58(3):601-7.

PMID:
10953054
38.

Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.

Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF, Benya RV.

Cell Growth Differ. 2000 Jul;11(7):385-93.

39.

Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression.

Marrero JA, Matkowskyj KA, Yung K, Hecht G, Benya RV.

Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G797-804.

40.

US academic digestive disease sites on the internet.

Benya RV.

Am J Gastroenterol. 2000 Mar;95(3):817-20. No abstract available.

PMID:
10710086
42.
43.

Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model.

Matkowskyj KA, Marrero JA, Carroll RE, Danilkovich AV, Green RM, Benya RV.

Am J Physiol. 1999 Aug;277(2):G455-62. doi: 10.1152/ajpgi.1999.277.2.G455.

PMID:
10444460
44.

Pathogenic Escherichia coli increase Cl- secretion from intestinal epithelia by upregulating galanin-1 receptor expression.

Hecht G, Marrero JA, Danilkovich A, Matkowskyj KA, Savkovic SD, Koutsouris A, Benya RV.

J Clin Invest. 1999 Aug;104(3):253-62.

45.
46.

Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans.

Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, Benya RV.

Am J Physiol. 1999 Mar;276(3):G655-65. doi: 10.1152/ajpgi.1999.276.3.G655.

PMID:
10070042
47.
48.

Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl- secretion.

Benya RV, Marrero JA, Ostrovskiy DA, Koutsouris A, Hecht G.

Am J Physiol. 1999 Jan;276(1):G64-72. doi: 10.1152/ajpgi.1999.276.1.G64.

PMID:
9886980
49.

Electrophysiological characterization of human distal colon epithelium isolated using a novel technique.

Marrero JA, Ostrovskiy DA, Matkowskyj KA, Koutsouris S, Hecht G, Benya RV.

Dig Dis Sci. 1998 Nov;43(11):2439-45.

PMID:
9824131
50.

Cloning, chromosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN1R).

Lorimer DD, Matkowskj K, Benya RV.

Biochem Biophys Res Commun. 1997 Dec 18;241(2):558-64.

PMID:
9425310

Supplemental Content

Support Center